Back to state act
Description
On 26 March 2020, the Norwegian Medicines Agency introduced a notification requirement on exports of four COVID-19 related pharmaceutical goods. These are immunoglobulin, salbutamol, fluticasone and i...
Sign in to see full description
Intervention Details
Intervention Type
Export licensing requirement
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
26 Mar 2020
Revocation date
01 Jul 2023
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 6 products
Threads
See all
This intervention is not part of any Thread yet.